Immunoproteasomes shape the transcriptome and regulate the function of dendritic cells

Journal of Immunology

Volumn 193, Issue 3, 2014, Pages 1121-1132

  De Verteuil, Danielle A ^a,b   Rouette, Alexandre ^a,b   Hardy, Marie Pierre ^a,b   Lavallée, Stéphanie ^a   Trofimov, Assya ^a   Gaucher, Étienne ^a   Perreault, Claude ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOPROTEASOME; INTERFERON; PROTEASOME; STAT PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; IMMUNOPHENOTYPING; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FUNCTION; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BONE MARROW CELLS; CELL LINE; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PRIMARY CELL CULTURE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84906085948     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400871     Document Type: Article

References (56)

1. Glickman, M. H., and A. Ciechanover. 2002. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82: 373-428.
2. Osterloh, P., K. Linkemann, S. Tenzer, H. G. Rammensee, M. P. Radsak, D. H. Busch, and H. Schild. 2006. Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses. Proc. Natl. Acad. Sci. USA 103: 5042-5047.
3. Dalet, A., V. Stroobant, N. Vigneron, and B. J. Van den Eynde. 2011. Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome. Eur. J. Immunol. 41: 39-46.
4. de Verteuil, D., T. L. Muratore-Schroeder, D. P. Granados, M. H. Fortier, M. P. Hardy, A. Bramoullé, E. Caron, K. Vincent, S. Mader, S. Lemieux, et al. 2010. Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol. Cell. Proteomics 9: 2034-2047.
5. Kincaid, E. Z., J. W. Che, I. York, H. Escobar, E. Reyes-Vargas, J. C. Delgado, R. M. Welsh, M. L. Karow, A. J. Murphy, D. M. Valenzuela, et al. 2012. Mice completely lacking immunoproteasomes show major changes in antigen presentation. Nat. Immunol. 13: 129-135.
6. Princiotta, M. F., D. Finzi, S. B. Qian, J. Gibbs, S. Schuchmann, F. Buttgereit, J. R. Bennink, and J. W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
7. López-Otín, C., M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 2013. The hallmarks of aging. Cell 153: 1194-1217.
8. van Deventer, S., and J. Neefjes. 2010. The immunoproteasome cleans up after inflammation. Cell 142: 517-518.
9. Spaapen, R. M., and J. Neefjes. 2012. Immuno-waste exposure and further management. Nat. Immunol. 13: 109-111.
10. Muchamuel, T., M. Basler, M. A. Aujay, E. Suzuki, K. W. Kalim, C. Lauer, C. Sylvain, E. R. Ring, J. Shields, J. Jiang, et al. 2009. A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat. Med. 15: 781-787.
11. Hensley, S. E., D. Zanker, B. P. Dolan, A. David, H. D. Hickman, A. C. Embry, C. N. Skon, K. M. Grebe, T. A. Griffin,W. Chen, et al. 2010. Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses. J. Immunol. 184: 4115-4122.
12. Kitamura, A., Y. Maekawa, H. Uehara, K. Izumi, I. Kawachi, M. Nishizawa, Y. Toyoshima, H. Takahashi, D. M. Standley, K. Tanaka, et al. 2011. A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans. J. Clin. Invest. 121: 4150-4160.
13. Atkinson, S. P., J. Collin, N. Irina, G. Anyfantis, B. K. Kyung, M. Lako, and L. Armstrong. 2012. A putative role for the immunoproteasome in the maintenance of pluripotency in human embryonic stem cells. Stem Cells 30: 1373-1384.
14. Ferrington, D. A., S. A. Hussong, H. Roehrich, R. J. Kapphahn, S. M. Kavanaugh, N. D. Heuss, and D. S. Gregerson. 2008. Immunoproteasome responds to injury in the retina and brain. J. Neurochem. 106: 158-169.
15. Catalgol, B. 2012. Proteasome and cancer. Prog. Mol. Biol. Transl. Sci. 109: 277-293.
16. Geng, F., S. Wenzel, and W. P. Tansey. 2012. Ubiquitin and proteasomes in transcription. Annu. Rev. Biochem. 81: 177-201.
17. Huber, E. M., M. Basler, R. Schwab, W. Heinemeyer, C. J. Kirk, M. Groettrup, and M. Groll. 2012. Immuno-and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity. Cell 148: 727-738.
18. St-Pierre, C., S. Brochu, J. R. Vanegas, M. Dumont-Lagacé, S. Lemieux, and C. Perreault. 2013. Transcriptome sequencing of neonatal thymic epithelial cells. Sci. Rep. 3: 1860.
19. Anders, S., and W. Huber. 2010. Differential expression analysis for sequence count data. Genome Biol. 11: R106.
20. Breuer, K., A. K. Foroushani, M. R. Laird, C. Chen, A. Sribnaia, R. Lo, G. L. Winsor, R. E. Hancock, F. S. Brinkman, and D. J. Lynn. 2013. InnateDB: systems biology of innate immunity and beyond-recent updates and continuing curation. Nucleic Acids Res. 41: D1228-D1233.
21. Ebstein, F., A. Voigt, N. Lange, A. Warnatsch, F. Schröter, T. Prozorovski, U. Kuckelkorn, O. Aktas, U. Seifert, P. M. Kloetzel, and E. Krüger. 2013. Immunoproteasomes are important for proteostasis in immune responses. Cell 152: 935-937.
22. Fiala, G. J., W. W. Schamel, and B. Blumenthal. 2011. Blue native polyacrylamide gel electrophoresis (BN-PAGE) for analysis of multiprotein complexes from cellular lysates. J. Vis. Exp. 48: e2164.
23. Meunier, M. C., C. Baron, and C. Perreault. 2009. Two host factors regulate persistence of H7-specific T cells injected in tumor-bearing mice. PLoS ONE 4: e4116.
24. Leignadier, J., M. P. Hardy, M. Cloutier, J. Rooney, and N. Labrecque. 2008. Memory T-lymphocyte survival does not require T-cell receptor expression. Proc. Natl. Acad. Sci. USA 105: 20440-20445.
25. Gudmundsdottir, H., A. D. Wells, and L. A. Turka. 1999. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J. Immunol. 162: 5212-5223.
26. Blais, M. E., S. Brochu, M. Giroux, M. P. Bélanger, G. Dulude, R. P. Sékaly, and C. Perreault. 2008. Why T cells of thymic versus extrathymic origin are functionally different. J. Immunol. 180: 2299-2312.
27. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31: 563-604.
28. Guillaume, B., J. Chapiro, V. Stroobant, D. Colau, B. Van Holle, G. Parvizi, M. P. Bousquet-Dubouch, I. Théate, N. Parmentier, and B. J. Van den Eynde. 2010. Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules. Proc. Natl. Acad. Sci. USA 107: 18599-18604.
29. Granados, D. P., P. L. Tanguay, M. P. Hardy, E. Caron, D. de Verteuil, S. Meloche, and C. Perreault. 2009. ER stress affects processing of MHC class Iassociated peptides. BMC Immunol. 10: 10.
30. Krishnan, N., T. T. Lam, A. Fritz, D. Rempinski, K. O'Loughlin, H. Minderman, R. Berezney, W. F. Marzluff, and R. Thapar. 2012. The prolyl isomerase Pin1 targets stem-loop binding protein (SLBP) to dissociate the SLBP-histone mRNA complex linking histone mRNA decay with SLBP ubiquitination. Mol. Cell. Biol. 32: 4306-4322.
31. Li, M. L., J. Defren, and G. Brewer. 2013. Hsp27 and F-box protein b-TrCP promote degradation of mRNA decay factor AUF1. Mol. Cell. Biol. 33: 2315-2326.
32. Breig, O., and F. Baklouti. 2013. Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation. PLoS ONE 8: e59137.
33. Abramson, J., M. Giraud, C. Benoist, and D. Mathis. 2010. Aire's partners in the molecular control of immunological tolerance. Cell 140: 123-135.
34. Dantuma, N. P., T. A. Groothuis, F. A. Salomons, and J. Neefjes. 2006. A dynamic ubiquitin equilibrium couples proteasomal activity to chromatin remodeling. J. Cell Biol. 173: 19-26.
35. Szklarczyk, D., A. Franceschini, M. Kuhn, M. Simonovic, A. Roth, P. Minguez, T. Doerks, M. Stark, J. Muller, P. Bork, et al. 2011. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 39: D561-D568.
36. Brckalo, T., F. Calzetti, B. Pérez-Cabezas, F. E. BorrÀs, M. A. Cassatella, and M. López-Botet. 2010. Functional analysis of the CD300e receptor in human monocytes and myeloid dendritic cells. Eur. J. Immunol. 40: 722-732.
37. Yarovinsky, F., D. Zhang, J. F. Andersen, G. L. Bannenberg, C. N. Serhan, M. S. Hayden, S. Hieny, F. S. Sutterwala, R. A. Flavell, S. Ghosh, and A. Sher. 2005. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626-1629.
38. Stoitzner, P., and N. Romani. 2011. Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells. Eur. J. Immunol. 41: 2526-2529.
39. Blasius, A. L., and M. Colonna. 2006. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol. 27: 255-260.
40. Gaiser, M. R., T. Lämmermann, X. Feng, B. Z. Igyarto, D. H. Kaplan, L. Tessarollo, R. N. Germain, and M. C. Udey. 2012. Cancer-associated epithelial cell adhesion molecule (EpCAM; CD326) enables epidermal Langerhans cell motility and migration in vivo. Proc. Natl. Acad. Sci. USA 109: E889-E897.
41. Ohno, M., T. Hirata, M. Enomoto, T. Araki, H. Ishimaru, and T. A. Takahashi. 2000. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol. Immunol. 37: 407-412.
42. Wang, M., Y. Zhang, Y. Chen, L. Zhang, X. Lu, and Z. Chen. 2011. Mannanbinding lectin regulates dendritic cell maturation and cytokine production induced by lipopolysaccharide. BMC Immunol. 12: 1.
43. Eisenbarth, S. C., A. Williams, O. R. Colegio, H. Meng, T. Strowig, A. Rongvaux, J. Henao-Mejia, C. A. Thaiss, S. Joly, D. G. Gonzalez, et al. 2012. NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells. Nature 484: 510-513.
44. Struyf, S., L. Salogni, M. D. Burdick, J. Vandercappellen, M. Gouwy, S. Noppen, P. Proost, G. Opdenakker, M. Parmentier, C. Gerard, et al. 2011. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. Blood 117: 480-488.
45. Pierre, P. 2009. Immunity and the regulation of protein synthesis: surprising connections. Curr. Opin. Immunol. 21: 70-77.
46. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
47. Murphy, K. M. 2013. Transcriptional control of dendritic cell development. Adv. Immunol. 120: 239-267.
48. Miller, J. C., B. D. Brown, T. Shay, E. L. Gautier, V. Jojic, A. Cohain, G. Pandey, M. Leboeuf, K. G. Elpek, J. Helft, et al.; Immunological Genome Consortium. 2012. Deciphering the transcriptional network of the dendritic cell lineage. Nat. Immunol. 13: 888-899.
49. Gautier, E. L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft, A. Chow, K. G. Elpek, S. Gordonov, et al.; Immunological Genome Consortium. 2012. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13: 1118-1128.
50. Joffre, O., M. A. Nolte, R. Spörri, and C. Reis e Sousa. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol. Rev. 227: 234-247.
51. Sancho, D., O. P. Joffre, A. M. Keller, N. C. Rogers, D. Martínez, P. Hernanz-Falcón, I. Rosewell, and C. Reis e Sousa. 2009. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458: 899-903.
52. Tippmann, S. C., R. Ivanek, D. Gaidatzis, A. Schöler, L. Hoerner, E. van Nimwegen, P. F. Stadler, M. B. Stadler, and D. Schübeler. 2012. Chromatin measurements reveal contributions of synthesis and decay to steady-state mRNA levels. Mol. Syst. Biol. 8: 593.
53. Mishto, M., F. Luciani, H. G. Holzhütter, E. Bellavista, A. Santoro, K. Textoris-Taube, C. Franceschi, P. M. Kloetzel, and A. Zaikin. 2008. Modeling the in vitro 20S proteasome activity: the effect of PA28-alphabeta and of the sequence and length of polypeptides on the degradation kinetics. J. Mol. Biol. 377: 1607-1617.
54. Toes, R. E., A. K. Nussbaum, S. Degermann, M. Schirle, N. P. Emmerich, M. Kraft, C. Laplace, A. Zwinderman, T. P. Dick, J. Müller, et al. 2001. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products. J. Exp. Med. 194: 1-12.
55. Macagno, A., M. Gilliet, F. Sallusto, A. Lanzavecchia, F. O. Nestle, and M. Groettrup. 1999. Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation. Eur. J. Immunol. 29: 4037-4042.
56. Vacchelli, E., I. Vitale, A. Eggermont, W. H. Fridman, J. Fučíková, I. Cremer, J. Galon, E. Tartour, L. Zitvogel, G. Kroemer, and L. Galluzzi. 2013. Trial watch: Dendritic cell-based interventions for cancer therapy. OncoImmunology 2: e25771